Cancer Risk in Patients with Rheumatoid Arthritis Receiving Biologic and Targeted Synthetic Disease Modifying Antirheumatic Drugs: Data from a Multicenter National Real-World Registry
24/11/2025
Molina J et al.
Congreso SER Madrid
https://static.elsevier.es/reuma/reumacongreso2025.pdf
SER 2025